Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia
Recruiting
Observational Study
Anemia
Pregnancy
Micronutrients
Supplement
Health Systems
Supply Chain Vulnerabilities
Adherence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 710 (estimated)
- Sponsor
- University of British Columbia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Malnutrition among pregnant women in low- and middle-income countries (LMICs) can cause micronutrient deficiencies that result in adverse maternal and neonatal health outcomes. The World Health Organization has recently recommended antenatal multiple micronutrient supplementation (MMS) that includes iron and folic acid (IFA) to improve maternal and neonatal health outcomes. MMS likely provides add…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
For the cohort of pregnant individuals consuming MMS:
Inclusion Criteria:
* Current pregnant
* At least 18 years of age
* Have attended at least one ANC visit at a health center or hospital in Takeo during the study period
* Can provide a functioning phone number for follow-up contact
* Willingnes…
Contacts
Meng Sokchea Program Manager, Helen Keller International, MD
+855 023 213 217
CONTACT